---
$id: https://graph.org.ai/products/commodity/51191535
$type: Product
source: UNSPSC
code: "51191535"
title: "Brocrinat"
class: "51191500"
classTitle: "Diuretics"
family: "51190000"
familyTitle: "Agents affecting water and electrolytes"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brocrinat

**UNSPSC Code**: 51191535
**Class**: [Diuretics](Diuretics.mdx)
**Family**: [Agents affecting water and electrolytes](../Agents affecting water and electrolytes.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diuretic with the molecular formula C15H9BrFNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6ESF2Z39VZ, chemically known as acetic acid, ((7-bromo-3-(2-fluorophenyl)-1,2-benzisoxazol-6-yl)oxy)- but generally known as brocrinat, which bears US NIH Compound Identifier 51603. European Medicines Agency schedules Brocrinat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05897MIG. The term BROCRINAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BROCRINAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule brocrinat under HS 29349990 and SITC 51579. As of Q4 2014, BROCRINAT remains the US FDA Preferred Term for this commodity. Brocrinat bears US NLM identifiers UMLS ID C2825442 and NCI Concept Code C81073. SMILES: BRC1C2ONC(C2CCC1OCC(=O)O)C1C(F)CCCC1.

